NYSE:V
NYSE:VDiversified Financial

Is Visa’s Premium Price Still Justified After Its Digital Payments Expansion in 2025?

Wondering if Visa at around $346 is still a smart buy after its long run, or if most of the upside is already priced in? This breakdown will help you separate durable value from headline hype. Despite a modest 0.5% slip over the last week, Visa is still up 6.8% over the past month and 10.1% year to date, with a strong 71.9% gain over both 3 and 5 years that keeps expectations high. Recent headlines have focused on Visa expanding its digital payments ecosystem and striking new partnerships...
NasdaqGS:CASY
NasdaqGS:CASYConsumer Retailing

Earnings Beat, New Stores and Capital Returns Could Be A Game Changer For Casey's General Stores (CASY)

Earlier this month, Casey's General Stores reported second-quarter 2025 results showing higher sales of US$4,506.08 million and net income of US$206.34 million, alongside updated fiscal 2026 guidance, new store growth plans, a continued quarterly dividend of US$0.57 per share, and progress on its long-running share repurchase program. The combination of stronger earnings, expectations for at least 80 new stores in fiscal 2026, and reaffirmed capital returns offers fresh insight into how...
NYSEAM:UEC
NYSEAM:UECOil and Gas

Uranium Energy (UEC): Valuation Check After US Policy Tailwinds and Narrowing Quarterly Losses

Uranium Energy (UEC) just delivered a first quarter update that trimmed its net loss to about half of last year, and it landed against a backdrop of increasingly supportive U.S. uranium policy. See our latest analysis for Uranium Energy. Despite a choppy recent stretch, with a negative 7 day share price return, Uranium Energy still trades at about $11.93 and has delivered a powerful 1 year total shareholder return of roughly 69%. This reflects growing confidence in U.S. focused uranium names...
NasdaqGS:HWC
NasdaqGS:HWCBanks

Is Hancock Whitney Still Attractively Priced After Its 120% Five Year Share Price Surge?

If you are wondering whether Hancock Whitney is still reasonably priced after its run, you are not alone. This stock has quietly turned into one that valuation focused investors can no longer ignore. Over the last month the share price has climbed 15.9%, contributing to a 24.9% gain over the past year and a 120.1% rise over five years. Moves like this can signal both growing optimism and a shift in how the market views its risk profile. Recent headlines around regional banks, including...
NYSE:AIR
NYSE:AIRAerospace & Defense

Is AAR’s Valuation Still Attractive After Its Strong Multi Year Share Price Rally?

If you are wondering whether AAR is still worth buying after its big run, or if most of the upside has already been priced in, you are not alone. The stock has cooled slightly over the last week, down 2.2%, but it is still up 4.2% over the past month, 32.9% year to date, 35.2% over 1 year, 90.9% over 3 years, and 130.7% over 5 years. This shows that investors have been steadily rerating the story. Recent headlines have focused on AAR winning new long term aviation services and parts supply...
NYSE:KD
NYSE:KDIT

Kyndryl (KD): Revisiting Valuation After New AI and Quantum-Safe Security Initiatives

Kyndryl Holdings (KD) has been busy reshaping its story around AI and next generation security, from quantum safe assessments to agentic AI for mainframes, and the stock is starting to reflect that pivot. See our latest analysis for Kyndryl Holdings. Those AI and quantum safe moves are landing just as sentiment starts to turn, with a roughly 14 percent 1 month share price return partially offsetting a weak year to date. At the same time, the 3 year total shareholder return above 140 percent...
NYSE:OC
NYSE:OCBuilding

What Owens Corning (OC)'s Innovation Leadership Shake-Up Means For Shareholders

Earlier this week, Owens Corning announced that José Méndez-Andino, Ph.D., has been promoted to Executive Vice President and Chief Innovation Officer, expanding his remit to lead a new innovation center of excellence focused on product stewardship, core process and product innovation, capital projects, and new building product applications. This move elevates the architect behind more than 220 product launches over the past five years into a broader innovation leadership role, signaling an...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Tempus AI (TEM): Valuation Check After New Breast Cancer Research Abstracts Gain Symposium Spotlight

Tempus AI (TEM) just drew fresh attention after ten of its oncology research abstracts were accepted for the 2025 San Antonio Breast Cancer Symposium, spotlighting how its real world data platform is being applied in metastatic breast cancer. See our latest analysis for Tempus AI. Despite the excitement around these SABCS abstracts, Tempus AI's recent performance has been choppy, with a 7 day share price return of minus 15.77 percent and a 90 day share price return of minus 29.5 percent. At...
NYSEAM:BMNR
NYSEAM:BMNRSoftware

Bitmine Immersion Technologies (BMNR) Is Down 18.4% After Aggressively Expanding Its Ethereum Treasury And Staking Ambitions

In recent weeks, BitMine Immersion Technologies has expanded its Ethereum treasury to roughly 3.97 million ETH, outlined plans for its MAVAN staking rollout in early 2026, and confirmed the upcoming departure of CFO and director Raymond Mow, whose resignation was not tied to any operational disputes. At the same time, Cathie Wood’s ARK Invest has been buying tens of millions of US dollars’ worth of BitMine shares during a sector downturn, effectively endorsing the company’s shift toward an...
NYSE:CRS
NYSE:CRSAerospace & Defense

Does NYSE Composite Inclusion Alter the Bull Case For Carpenter Technology (CRS)?

Carpenter Technology’s shares were recently added to the NYSE Composite index, reflecting the specialty alloys producer’s growing presence across North America, Europe, Asia Pacific and other international markets. This index inclusion can broaden the company’s investor base by increasing visibility, trading liquidity and alignment with index-tracking institutional portfolios. We’ll explore how Carpenter Technology’s addition to the NYSE Composite, and the extra visibility it brings, may...
NYSE:OBK
NYSE:OBKBanks

Origin Bancorp (OBK): Reassessing Valuation After Its Recent Inclusion in the Russell 1000 Index

Origin Bancorp, Inc., a regional bank based in Ruston, Louisiana, was recently added to the Russell 1000 Index, a shift that could quietly reshape how larger institutions and index followers treat the stock. See our latest analysis for Origin Bancorp. That backdrop helps explain why investors have pushed Origin’s share price to about $39.76, with a 1 month share price return of 17.04 percent and a 1 year total shareholder return of 23.34 percent. This suggests momentum is building rather than...
NYSE:EPD
NYSE:EPDOil and Gas

Is Jim Cramer’s NGL Endorsement Altering The Investment Case For Enterprise Products Partners (EPD)?

Earlier this week, TV commentator Jim Cramer publicly highlighted Enterprise Products Partners as his preferred pick in its peer group, emphasizing its consistent distribution growth, strong yield, and deep expertise in natural gas liquids while playing down concerns around ethane and NGL softness. Investors appear to have reacted strongly to this endorsement, underscoring how influential media commentary can rapidly shift sentiment around a midstream operator that is otherwise seen as a...
NYSE:CB
NYSE:CBInsurance

Chubb (CB): Reassessing Valuation as Analyst Optimism Builds Ahead of Upcoming Earnings

Chubb (CB) has been climbing quietly, and the latest leg of that move looks tied less to headlines and more to rising confidence ahead of earnings, as estimate revisions trend higher. See our latest analysis for Chubb. At a share price of $310.89, Chubb’s recent climb, including a solid multi month share price return and a strong multi year total shareholder return, suggests momentum is still building as investors warm to its growth and risk profile, supported by fresh leadership appointments...
NYSE:UTI
NYSE:UTIConsumer Services

Universal Technical Institute (UTI): Valuation Check After Hyundai’s IONIQ 5 EV Donation and EV Training Push

Hyundai Motor America’s donation of 18 IONIQ 5 EVs to Universal Technical Institute (UTI) is not just a classroom upgrade; it is a fresh data point for investors watching how UTI monetizes the EV skills gap. See our latest analysis for Universal Technical Institute. The Hyundai partnership and UTI’s upcoming investor-facing events, including a non-deal roadshow and conference appearances later this month, arrive as the stock trades at about $26.60, with a 1-year total shareholder return of...
NasdaqGS:BOKF
NasdaqGS:BOKFBanks

Assessing BOK Financial’s (BOKF) Valuation After Its Recent Share Price Outperformance

Recent Performance Puts BOK Financial In Focus BOK Financial (BOKF) has quietly outperformed many regional peers, with the stock up about 14% over the past month and roughly 7% over the past 3 months, drawing fresh investor attention. See our latest analysis for BOK Financial. That surge sits on top of an 11.7% year to date share price return and a 12.7% one year total shareholder return, suggesting momentum is quietly building as markets reassess BOK Financial’s earnings power and risk...
NYSE:OSK
NYSE:OSKMachinery

How Oshkosh’s CES 2026 Autonomy and AI Showcase Could Shape OSK’s Technology Narrative

Oshkosh Corporation has announced plans to return to CES 2026 in Las Vegas, where it will showcase advances in autonomy, artificial intelligence, connectivity and electrification across its purpose-built vehicles, including award-winning products in robotics and sustainable airport rescue and firefighting. The CES 2026 Innovation Awards for Oshkosh’s JLG Boom Lift with Robotic End Effector and Striker Volterra Electric ARFF spotlight how the company is positioning its technology as a...
NasdaqGS:BILI
NasdaqGS:BILIInteractive Media and Services

Is Bilibili Finally Offering Value After Its 2025 Share Price Rebound?

If you are wondering whether Bilibili is finally starting to look like value rather than just a story stock, you are not alone. This is exactly what we are going to unpack. The share price is up 41.7% year to date and 23.9% over the last year. It has slipped slightly by 1.3% over the past week and 4.1% over the last month, reminding investors that the ride is still bumpy after a 70.4% drop over 5 years. Much of this renewed interest has been driven by optimism around Bilibili's progress in...
NasdaqGS:SMCI
NasdaqGS:SMCITech

Super Micro (SMCI): Valuation Check After New Liquid‑Cooled NVIDIA Blackwell AI Systems and Raised Guidance

Super Micro Computer (SMCI) just doubled down on AI infrastructure, rolling out new liquid cooled NVIDIA Blackwell systems while backing that tech push with over $13 billion in firm orders and higher long term revenue guidance. See our latest analysis for Super Micro Computer. Despite the upgraded AI roadmap, SMCI’s share price return has cooled recently, with double digit declines over the past month and quarter. However, three and five year total shareholder returns remain exceptionally...
NasdaqGS:DOCU
NasdaqGS:DOCUSoftware

Is DocuSign (DOCU) Undervalued After Its Recent Share Price Slide? A Fresh Look at the Valuation

DocuSign (DOCU) has been a tough hold lately, with the stock down around 28% over the past year even as revenue and net income keep growing, which raises a simple question for investors. See our latest analysis for DocuSign. That slide reflects fading short term momentum, with a roughly 20% 90 day share price return decline and a 1 year total shareholder return of about negative 28%, even though longer term holders still sit on a positive 3 year total shareholder return. If DocuSign has you...
NasdaqGM:WVE
NasdaqGM:WVEPharmaceuticals

Wave Life Sciences (WVE): Valuation Check After Positive WVE-007 Obesity Data And GlaxoSmithKline Backing

Wave Life Sciences (WVE) is back on investors radar after interim Phase 1 data for its obesity candidate WVE-007 showed healthier body composition changes along with a clean safety profile, sparking renewed interest. See our latest analysis for Wave Life Sciences. The excitement around WVE 007, along with Wave Life Sciences recent $350 million follow on equity raise and fresh backing from GlaxoSmithKline, has powered a 118.57% 1 month share price return and a 142.43% three year total...
NYSE:SMR
NYSE:SMRElectrical

NuScale Power (SMR): Reassessing Valuation After a Sharp Multi‑Month Share Price Slide

NuScale Power (SMR) has been on a rough slide, with the stock down about 27% this month and roughly 66% over the past 3 months, even as revenue growth remains strong. See our latest analysis for NuScale Power. The latest slide comes after a sharp run up in prior years, with NuScale still sitting on a solid three year total shareholder return despite the recent weak share price momentum and concerns about execution risk resurfacing. If NuScale’s volatility has you rethinking your exposure to...
NYSE:O
NYSE:ORetail REITs

How Realty Income’s Latest Dividend Bump and AFFO Coverage Will Impact Realty Income (O) Investors

Earlier this month, Realty Income Corporation increased its monthly common stock cash dividend to US$0.2700 per share from US$0.2695, payable on January 15, 2026 to shareholders of record as of December 31, 2025, lifting the annualized payout to US$3.240 per share. This latest raise, although small, reinforces Realty Income’s multi-decade pattern of consistent dividend growth, supported by expanding European investments, high-profile property deals, and a dividend payout backed by adjusted...
NYSE:KNSL
NYSE:KNSLInsurance

Is Kinsale Capital Group Attractively Priced After Recent Share Weakness In 2025?

If you are wondering whether Kinsale Capital Group is a bargain or just fairly priced after its big run in recent years, you are not alone. In this piece we break down what the current share price is really implying. The stock has inched up 2.0% over the last week and 0.2% over the last month, but that is against a tougher backdrop of a -12.8% year to date and -15.2% over the last year, even after longer term gains of 43.8% over 3 years and 92.7% over 5 years. Those moves have played out as...
NasdaqGS:WTW
NasdaqGS:WTWInsurance

Is It Too Late To Consider Willis Towers Watson After Strong Multi Year Share Price Gains

Wondering if Willis Towers Watson at around $329 a share is still worth buying, or if most of the upside has already been priced in? You are not the only one trying to figure out whether this insurance and advisory giant still offers genuine value. Over the last week the stock is up 1.3%, and it has climbed 3.2% over the last month. Zooming out, it is up 6.6% year to date and 7.2% over the past year, building on a strong 41.5% gain over three years and 66.3% over five years. Those steady...